NYSE - Nasdaq Real Time Price • USD Humana Inc. (HUM) Follow Compare 296.91 +2.68 +(0.91%) At close: 4:00:02 PM EST 296.91 0.00 (0.00%) After hours: 4:42:31 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Humana (NYSE:HUM) shareholders have endured a 30% loss from investing in the stock a year ago Humana Inc. ( NYSE:HUM ) shareholders should be happy to see the share price up 14% in the last month. But in truth the... Jim Cramer on Humana Inc. (HUM): ‘Medicare Provisions Were Much Better Than Expected On Friday. Should Really Help Humana All Day’ We recently compiled a list of the Jim Cramer Recently Discussed These 15 Stocks & The California Wildfires. In this article, we are going to take a look at where Humana Inc. (NYSE:HUM) stands against the other stocks Jim Cramer recently discussed. In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer commented on […] Here's Why it is Prudent for Investors to Hold Humana Stock for Now HUM remains well-poised for growth, attributable to improved premiums, contract wins, acquisitions, collaborations and growing cash reserves. UnitedHealth’s Challenges With High Medical Costs Continue The company’s shares fell in premarket trading following the healthcare firms first earnings since the killing of executive Brian Thompson. Will UNH, HUM & CVS be the Top Beneficiaries of the $21B MA Boom? The government's payment rate directly impacts insurers' pricing, plan benefits and overall profitability. Company News for Jan 15, 2025 Companies in The News Are: KBH, BA, SHEL, HUM Humana Inc (NYSE:HUM): A Bullish Investment Perspective We came across a long thesis on Humana Inc (NYSE:HUM) on ValueInvestorsClub by ElCid. In this article we will summarize the bulls’ thesis on HUM. The company’s shares were trading at $260.73 when this thesis was published, vs. closing price of $287.36 on Jan 13th. Humana Inc (NYSE:HUM) is one of the largest private health […] Big Gains Ahead for Medicare Advantage Sellers as Payments Set to Grow As the largest MA plan sellers, UnitedHealth, Humana and CVS Health collectively account for nearly 60% of the market. Humana, UnitedHealth, CVS Jump On Potential Medicare Advantage Payment Boost This positive news overshadowed the negative impact of recent California wildfires on the insurance sector. Zacks Industry Outlook Highlights UnitedHealth, Humana and Centene UnitedHealth, Humana and Centene have been highlighted in this Industry Outlook article. 3 HMO Stocks Poised to Thrive Despite Industry Headwinds The Medical-HMO industry benefits from a growing customer base and contract wins. However, industry challenges like rising costs and workforce shortages remain a concern. UNH, HUM and CNC are likely to navigate industry storms. Humana Inc. to Release Fourth Quarter 2024 Results on February 11, 2025 LOUISVILLE, Ky., January 09, 2025--Humana Inc. (NYSE: HUM) will release its financial results for the fourth quarter 2024 (4Q24), as well as prepared management remarks (in PDF format), on Tuesday, February 11, 2025, at 6:30 a.m. Eastern time. The company will host a live question and answer session at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2025. Humana Earns Equality 100 Award in Human Rights Campaign Foundation’s 2025 Corporate Equality Index LOUISVILLE, Ky., January 07, 2025--Humana Earns Equality 100 Award in Human Rights Campaign Foundation’s 2025 Corporate Equality Index Humana price target raised to $290 from $260 at Truist Truist raised the firm’s price target on Humana (HUM) to $290 from $260 and keeps a Hold rating on the shares as part of a broader research note previewing 2025 for Healthcare Services. The firm sees the outlook for the group as “mixed”, with bullish stance on the underlying demand drivers and overarching sector tailwinds that include demographics, value-based care, and core demand being offset by heightened concern around a likely more cost focused government backdrop. Selectivity is key and ca Healthcare Executives Bullish on 2025: But Why Are Stocks Slipping? Improving the consumer experience, engagement and trust is emerging as a top strategy for healthcare companies. How Health Insurers Racked Up Billions in Extra Payments From Medicare Advantage The Wall Street Journal’s yearlong investigation into Medicare’s private insurers relied on exclusive access to billions of records of Medicare services. Is Humana Inc. (HUM) the Best Pharma Dividend Stock to Buy In 2024? We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a look at where Humana Inc. (NYSE:HUM) stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower […] Humana (NYSE:HUM) Seems To Use Debt Quite Sensibly David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the... UnitedHealth’s Army of Doctors Helped It Collect Billions More From Medicare The biggest Medicare Advantage insurer presented physicians with checklists of potential diagnose.; “I didn’t think I was obese,” one suspicious patient told his doctor. Is Humana Inc.'s (NYSE:HUM) Recent Price Movement Underpinned By Its Weak Fundamentals? Humana (NYSE:HUM) has had a rough three months with its share price down 18%. It seems that the market might have... Performance Overview Trailing total returns as of 1/30/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return HUM S&P 500 YTD +17.18% +2.78% 1-Year -17.95% +23.20% 3-Year -21.13% +36.99%